Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-581-7 | CAS number: 4418-61-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The sequential testing strategy was used as it is recommended in supplement to TG 405 (2012). SAR systems are not applicable to this type of test item. Validated and accepted in vitro tests for eye corrosion/irritation have been conducted prior to decide performing the in vivo test. These were In vitro Skin Irritation Test (OECD TG 439 ) BCOP test (OECD TG No. 437) and In vitro Eye Irritation Test (OECD TG No.492). The results did not allow the classification of test item with regard to its potential to cause eye irritation or serious eye damage. Therefore it was decided to perform in vivo eye irritation study.
SKIN
- Study No. 413/17/4AC: 5-aminotetrazole - In vitro Skin Corrosion Test (EpiDermTM Model); VUOS CETA Report No.: 17-693 (acc. OECD TG No. 431)
Result: non-corrosive in the EpiDermTM model
- Study No. 413/17/4AI: 5-aminotetrazole - In vitro Skin Irritation Test (EpiDermTM Model); VUOS-CETA Report No. 17-780, 2017 (acc. OECD TG No. 439; EU Method B.46)
Result: no category with regard to skin irritation
EYE
- Study No. 413/17/5BCOP: 5-aminotetrazole - Bovine Corneal Opacity and Permeability Test; VUOS-CETA Report No. 17-760, 2018 (acc. OECD TG No. 437; EU Method B.47) Result: no prediction can be made
- Study No. 413/17/5AI: 5 -aminotetrazole - In vitro Eye Irritation Test (EpiOcularTM Model); VUOS-CETA Report No. 18 -12, 2018 (acc. OECD TG No.492)
Result: substance potentially requiring classification and labelling, further testing with other test methods required
Under the experimental design average viability of treated tissues by the test substance 5-aminotetrazole was 2.3 % of negative control average value i.e. viability was ≤ 60 %. The effect of the test substance was positive in EpiOcularTM model (tissues were damaged). According to the classification criteria, the test substance, 5-aminotetrazole, is identified as substance potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1). Further testing with other test methods will be required.
- Study No. 413/17/5: 5-aminotetrazole - Acute Eye Irritation/Corrosion; VUOS-CETA Report No. 18 -187, 2018 (acc. OECD TG No. 405, EU Method B.5)
Result: irritating for eye
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24.10. – 02.11.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- Adopted: July 29th, 2016
- Deviations:
- yes
- Remarks:
- The medium during MTT direct reduction test changed colour from red to yellow by low pH of the test substance. This deviation had no impact on the outcome of study.
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Remarks:
- a reconstructed human epidermal model EpiDerm™ (EPI-200, MatTek)
- Source species:
- human
- Cell type:
- other: normal human-derived epidermal keratinocytes
- Cell source:
- other: Keranocyte strain: 00267
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: The reconstructed human epidermal model EpiDerm™ (EPI-200, MatTek, Bratislava, SR)
- Tissue batch number(s): Lot No. 25851, kit B
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37±1°C
- Temperature of post-treatment incubation (if applicable): 37±1°C
REMOVAL OF TEST MATERIAL AND CONTROLS
tissues were thoroughly rinsed and blotted to remove the test substance (controls)
Detailed procedure is described in internal SOP M/46/3.
- Modifications to validated SOP: no
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration:
tissues were transferred to 24-well plates containing MTT medium (1 mg·mL-1)
- Incubation time: 3 hr
- Spectrophotometer: Libra S22. Isopropyl alcohol serves as a blank.
- Wavelength: 570±30 nm
NUMBER OF REPLICATE TISSUES: 3
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
1. Direct MTT reduction - functional check in tubes: the test substance does not reduce MTT directly.
2. Colour interference: colour of the test substance did not interfere with evaluation
3. MTT test
DECISION CRITERIA
According to the OECD TG 431 as well as to the EU Method B.40, the test substance is considered to be corrosive to skin:
i) if the viability after 3 minutes exposure is less than 50 %, or
ii) if the viability after 3 minutes exposure is greater than or equal to 50 % and the viability after 1 hour exposure is less than 15 %.
The test substance is considered to be non-corrosive to skin:
i) if the viability after 3 minutes exposure is greater than or equal to 50 % and the viability after 1 hour exposure is greater than or equal to 15 % - Control samples:
- yes, concurrent vehicle
- yes, concurrent positive control
- Amount/concentration applied:
- test substance C2: 25 mg of the test substance was placed directly atop to the previously moistened tissue (50 μL of H2O) and it was spread to match size of the tissue.
NC: 50 μL H2O tested with every exposure time
PC: 50 μL 8N KOH tested with every exposure time - Duration of treatment / exposure:
- 3 and 60 minutes
- Duration of post-treatment incubation (if applicable):
- 180 minutes (in MTT medium)
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 99.7
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Direct MTT reduction - functional check in tubes:
The test substance did not change colour from red to blue, so other steps were not employed.
- Colour interference
The test substance did not change colour, so other steps were not employed.
ACCEPTANCE OF RESULTS: All assay acceptance criteria have been met.
Negative control: The assay meets the acceptance criterion - OD570 of the NC tissues was 1.790 (3 min) and 1.747 (60 min) which is ≥ 0.8 and ≤ 2.8.
Positive control: Viability of tissues treated with 8N KOH after 60 minutes treatment was 4.6 % which is ≤ 15%.
Coefficient of variance: CV values in all triplets of tissues were ≤ 0.3 - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the above-described experimental design, the test substance 5-aminotetrazole was non-corrosive in In vitro Skin Corrosion Test on EpiDermTM tissues.
- Executive summary:
The test substance 5-aminotetrazole was assayed for the in vitro skin corrosion in human epidermal model EpiDermTM. The test was performed according to OECD Test Guideline 431, In Vitro Skin Corrosion: Human Skin Model Test, Adopted: 29th July 2016.
The test substance is white powder. There was no colour change after incubation with isopropanol and water.
Direct reduction test in test tubes was performed simultaneously. MTT medium changed colour from red to yellow. It was caused by low pH of the test substance. Hovewer the direct reduction of the MTT medium by the test substance was not observed.
In the MTT test, the test substance (25 mg) was placed atop the previously moistened tissue. Length of exposition was 3 and 60 minutes. Nine tissues were used for the experiment in each time, three per test substance (C2), three for the positive control (PC) and three for the negative control (NC).
After rinsing, tissues were incubated with MTT for three hours and then extracted with isopropyl alcohol overnight at refrigerator without shaking and than for two hours at room temperature with shaking. OD570 of isopropyl alcohol extracts was measured on a spectrophotometer. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.
Under the above-described experimental design, the average viability of tissues treated with the test substance 5-aminotetrazole was 100.0 % of the negative control average value after 3 minutes treatment and 99.7 % after 60 minutes treatment.
According to test guidelines, the test substance is considered to be non-corrosive to skin if the viability after 3 minutes exposure is greater than or equal to 50 % and the viability after 1 hour exposure is greater than or equal to 15 %.
In the experiment arrangement described above, the test substance 5-aminotetrazole was non-corrosive in the EpiDermTM model.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21.11.2017 - 24.11.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Adopted: 28th July, 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- Commission Regulation (EC) No. 761/2009, 23rd July 2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MatTek Protocol for: INVITRO EpiDermTM SKIN IRRITATION TEST For use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm, Model EPI-200-SIT,
- Version / remarks:
- Rev. 26/3/2012,1-37
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: tissue for research puposes from accredited institutions
- Source strain:
- other: Keratinocyte strain 00267
- Vehicle:
- physiological saline
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
Tissues: the reconstructed human epidermal model EpiDermTM (EPI-200 ver. 2.0, MatTek, Bratislava, Slovakia); Lot No. 25860 kit A
TEMPERATURE USED FOR TEST SYSTEM
culture conditions 37±1°C, 5±1 % CO2, moistened tissue
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: thoroughly rinsed with PBS
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg·mL-1
- Incubation time: 180±5 mins
- Spectrophotometer: Libra S22 at 570 nm. Isopropyl alcohol serves as a blank.
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
Based on Certificate of Analysis the model passed all parametres for viability, barrier function, sterility.
NUMBER OF REPLICATE TISSUES: 3
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
The test substance was fully rinsed off the tissues. No changes in tissue appearance were observed during the experiment.
The optical density of the extraction solvent alone should be sufficiently small, i.e. OD< 0.1. OD570 of isopropyl alcohol against empty cuvette was measured before measuring of tissue extract. OD570 of isopropyl alcohol was – 0.031.
MTT test: a single testing, composed of three replicate tissues, was run.
PREDICTION MODEL / DECISION CRITERIA
OECD Test Guideline No. 439 (1), par. 36:
- In case the test chemical is found to be non-corrosive (e.g., based on TG 430, 431 or 435), and shows tissue viability after exposure and post-treatment incubation is less than or equal (≤) to 50%, the test chemical is considered to be irritant to skin in accordance with UN GHS (3) Category 2.
- The test chemical may be considered as non-irritant to skin in accordance with UN GHS No Category if the tissue viability after exposure and post-treatment incubation is more than (>) 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 25 mg of the test substance was placed directly on tissue moistened with 25 µL of PBS and spread on the tissue surface.
NC: PBS (phosphate buffered saline), prepared in laboratory 29/09/17 exp. 29/03/18 (washing of tissues) and MatTek DPBS lot. No. 022217ZSB exp. 22/02/2018 (wetting of tissues, negative control)
PC: 5 % SDS (sodium dodecyl sulphate), MatTek, Lot No. 031617MGKA, exp. 16/03/2018 - Duration of treatment / exposure:
- 60 minutes
- Duration of post-treatment incubation (if applicable):
- 42 hours
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 100.7
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- All study acceptance criteria were fulfilled.
The mean OD570 of the NC tissue was 1.893 which meets the acceptance criteria of ≥ 0.8 and ≤ 2.8.
The mean viability of the PC tissues expressed as % of the negative control tissues was 2.4 % which meets the acceptance criterion of ≤ 20 %.
The SD calculated from individual % tissue viabilities of the 3 identically treated replicates was 0.2 % for the positive control, 3.0 % for negative control and 8.1 % for the test substance what is < 18 % in all cases. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the above-described experimental design, the average viability of tissues treated by the test substance, 5-aminotetrazole, was 100.7 % of negative control average value i.e. viability was > 50 %. The effect of the test substance was negative in EpiDermTM model.
According to the classification criteria given in this report, the test substance is considered to have no category in accordance with UN GHS and is therefore considered a non-irritant. - Executive summary:
The test substance, 5-aminotetrazole, was assayed for in vitro skin irritation in the human epidermal model EpiDermTM. The test was performed according to the OECD Test Guideline No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method (2015) and Protocol for: In Vitro EpiDermTMSkin Irritation Test Test for use with MatTek Corporation’s Reconstructed Human Epidermal Model EPI-200-SIT.
After pre-incubation of tissues, 25 mg of the test substance was placed directly on tissue and spread on the entire tissue surface. The length of exposure was 60 minutes. Three tissues were used for the test substance and for positive and negative controls.
After removal of the test substance, tissues were post-incubated for approximately 42 hours. Three hours incubation with MTT and two hours extraction period with shaking followed. Optical density (OD570) of isopropyl alcohol extracts was measured on a spectrophotometer. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.
No complementary experiments for correcting of colour interference and direct reduction were done, because they were performed as a part of the Study No. 413/17/4AC: 5 aminotetrazole - In vitro Skin Corrosion Test (EpiDermTM Model); VUOS CETA Report No.: 17-693. These experiments confirmed no direct reduction by the test substance and no color interference with the endpoint.
Under the above-described experimental design, average viability of treated tissues was 100.7 %, i.e. viability was > 50 %.
The effect of the test substance was negative in EpiDermTM model (tissues were not damaged).
According to the classification criteria given in report, the test substance, 5-aminotetrazole, is considered to have no category with regard to skin irritation.
Referenceopen allclose all
MTT test:
OD570values obtained at the MTT test, their averages, standard deviations (%), coefficients of variance and relative viabilities
Treatment 3 min | OD570 | mean | SD | CV | %NC | ||
water (NC) | 1.873 | 1.766 | 1.731 | 1.790 | 0.060 | 0.034 | 100.0 |
413/17 (C2) | 1.790 | 1.772 | 1.809 | 1.790 | 0.015 | 0.008 | 100.0 |
8N KOH (PC) | 0.156 | 0.126 | 0.120 | 0.134 | 0.016 | 0.118 | 7.5 |
Treatment 60 min | OD570 | mean | SD | CV | %NC | ||
water (NC) | 1.898 | 1.647 | 1.697 | 1.747 | 0.108 | 0.062 | 100.0 |
413/17 (C2) | 1.734 | 1.743 | 1.751 | 1.743 | 0.007 | 0.004 | 99.7 |
8N KOH (PC) | 0.066 | 0.083 | 0.091 | 0.080 | 0.010 | 0.130 | 4.6 |
MTT test
OD570values obtained at the MTT test, their averages, standard deviations (%) and relative viabilities
Treatment |
OD570 |
|
|
Avg |
SD |
%NC |
PBS (NC) |
1.968 |
1.834 |
1.876 |
1.893 |
0.056 |
|
viability (%NC) |
104.0 |
96.6 |
99.1 |
100.0 |
3.0 |
100.0 |
413/17 (C1) |
1.772 |
1.824 |
2.122 |
1.906 |
0.154 |
|
viability (%NC) |
93.6 |
96.4 |
112.1 |
100.7 |
8.1 |
100.7 |
5% SDS (PC) |
0.049 |
0.041 |
0.047 |
0.046 |
0.003 |
|
viability (%NC) |
2.589 |
2.166 |
2.483 |
2.4 |
0.2 |
2.4 |
PBS - phosphate buffered saline
SDS - sodium dodecyl sulphate
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29.11. - 30.11.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
- Version / remarks:
- Adopted 14th Feb 2017
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Breeding service CHOVSERVIS a.s., division TORO® Hlavečník, Hradec Králové, Czech Republic
- Characteristics of donor animals (e.g. age, sex, weight): The eyes were enucleated as soon as possible after death. No detergent was used. Only healthy animals (12 to 30 months old) considered suitable for entry into the human food chain were used as a source of corneas for use in the BCOP test.
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions):
The risk of contamination was minimized (e.g., by keeping the container containing the eyes on ice, by adding antibiotics to the HBSS used to store the eyes during transport (e.g., penicillin at 100 IU/mL and streptomycin at 100 μg/mL).
- Time interval prior to initiating testing: The time interval between collection of the eyes and use of corneas in the BCOP was minimized (typically collected and used on the same day). All eyes used in the assay were from the same group of eyes collected on a specific day.
- indication of any existing defects or lesions in ocular tissue samples: Only corneas from eyes free of defects including scratched, and neovascularisation were used. The isolated corneas, after achieve normal metabolic activity (inductive incubation at 32 ± 1°C for one hour), were examined again. The corneas that show macroscopic tissue damage (e.g., scratches, pigmentation, neovascularization) or a baseline opacity >7 opacity units were discarded. - Vehicle:
- Hank's balanced salt solution
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
2g of the test substance was suspended in 10 mL of 0.9% sodium chloride solution.
VEHICLE
Hank`s Balanced Salts Solution (HBSS)
- Lot/batch no. (if required): SLBL4865, Sigma-Aldrich - Duration of treatment / exposure:
- 4 hrs
- Duration of post- treatment incubation (in vitro):
- 1.5 hr
- Number of animals or in vitro replicates:
- The results were based on the selection criteria for the eyes, as well as the positive and negative control responses.
Number of corneas per group:
Exposed group (test item) - 3 corneas (No. 16, 18, 20)
Positive control group (20% Imidazole) – 3 corneas (No. 4, 5, 6)
Negative control group (0.9% NaCl) – 3 corneas (No. 1, 2, 3) - Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
Selection criteria for eyes used in BCOP: Only corneas from eyes free of defects including scratched, and neovascularisation were used. The isolated corneas, after achieve normal metabolic activity (inductive incubation at 32 ± 1°C for one hour), were examined again. The corneas that show macroscopic tissue damage (e.g., scratches, pigmentation, neovascularization) or a baseline opacity >7 opacity units were discarded.
Preparation: Corneas free of defects were dissected with a 2 to 3 mm rim of sclera remaining to assist in subsequent handling, with care taken to avoid damage to the corneal epithelium an endothelium.
Isolated corneas were mounted in specially designed corneal holders that consisted of anterior and posterior compartments, which interfaced with the epithelial and endothelial sides of the cornea, respectively.
Both chambers were filled to excess with pre-warmed Eagle's Minimum Essential Medium (EMEM). The device was then equilibrated at 32 ± 1°C for at least one hour in water bath to allow the corneas to equilibrate with the medium and to achieve normal metabolic activity, to the extent possible. Following the equilibration period, fresh pre-warmed EMEM was added to both chambers and a baseline opacity readings were taken for each cornea. Any corneas that showed macroscopic tissue damage (e.g., scratches, pigmentation, neovascularization) or a baseline opacity >7 opacity units were discarded.
Each test group (test item, concurrent negative and positive controls) consisted of the three eyes. The three corneas with opacity values close to the median value for all corneas were selected as negative control corneas. The remaining corneas were then distributed into treatment and positive control groups.
QUALITY CHECK OF THE ISOLATED CORNEAS
From 24 eyes the 5 eyes were eliminated after inductive incubation, because the baseline opacity values were >7. Nine corneas were used for the study (the corneas No. 1, 2, 3, 4, 5, 6, 16,18 and 20), 4 eyes was superfluous and 6 corneas were used for testing of other substances.
NUMBER OF REPLICATES
Number of corneas per group:
Exposed group (test item) - 3 corneas (No. 16, 18, 20)
Positive control group (20% Imidazole) – 3 corneas (No. 4, 5, 6)
Negative control group (0.9% NaCl) – 3 corneas (No. 1, 2, 3)
NEGATIVE CONTROL USED
0.9% NaCl
SOLVENT CONTROL USED (if applicable)
0.9% NaCl
POSITIVE CONTROL USED
20% Imidazole
APPLICATION DOSE AND EXPOSURE TIME
2g of the test substance was suspended in 10 mL of 0.9% sodium chloride solution.
Closed-chamber method was used, because the test item was applicable by micropipette. The test item (750 µL) to cover the epithelial side of the cornea is introduced into the anterior chamber through the dosing holes on the top surface of the chamber, and the holes were subsequently sealed with the chamber plugs during the exposure.
Exposure time: 4 hrs
TREATMENT METHOD: closed-chamber method
POST-INCUBATION PERIOD: 1.5 hr
REMOVAL OF TEST SUBSTANCE, POST-EXPOSURE INCUBATION
After the exposure period, the negative control substance, the positive control substance and the test item were removed from the anterior chamber with EMEM (containing phenol red - the effectiveness of rinsing acidic or alkaline materials). The corneas were given a final rinse with EMEM (without phenol red). The EMEM (without phenol red) was used as a final rinse to ensure removal of the phenol red from the anterior chamber prior to the opacity measurement. The anterior chamber was then refilled with fresh EMEM without phenol red. The opacity and permeability of each cornea were recorded.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: measured quantitatively with the aid of an opacitometer (Opacitometer, MC2 - Le spécialiste du laboratoire – France) resulting in opacity values measured on a continuous scale
- Corneal permeability: The amount of sodium fluorescein that crosses into the posterior chamber was quantitatively measured with the aid of UV/VIS spectrophotometry (Spectrophotometer GENESYSTM 10 UV/VIS Scanning). The values of absorbance measured at 490 nm were recorded as optical density (OD490) values. This term was used because the measuring is performed with visible light spectrophotometer using a standard 1 cm path length.
SCORING SYSTEM:
In Vitro Irritancy Score (IVIS)
IVIS = mean opacity value + (15 x mean permeability OD490 value)
DECISION CRITERIA:
IVIS UN GHS
≤ 3 No Category
> 3; ≤ 55 No prediction can be made
≥ 55 Category 1 - Irritation parameter:
- in vitro irritation score
- Value:
- 8.6
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS: Study acceptance criteria were fulfilled.
- Acceptance criteria met for negative control: The value of opacity for negative control (0.9% NaCl) obtained during the study was 0.73 and value of permeability was 0.008. The values obtained during this study not exceeded upper limits, so the study is considered acceptable.
- Acceptance criteria met for positive control: The value of IVIS for positive control (20% imidazole) obtained during the study was 72.71. This value is within the acceptance limit (one standard deviation of the current historical mean), so the study is considered acceptable. - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The In Vitro Irritancy Score (IVIS) for 5-aminotetrazole was 8.60. The corneas treated by the test item were without macroscopic damage.
This value of IVIS is > 3 and simultaneously ≤ 55 therefore the classification according to UN GHS criteria for eye irritation or serious eye damage is: no prediction can be made. - Executive summary:
The test item, 5-aminotetrazole, was tested for the evaluation the potential ocular corrosivity or severe irritancy as measured by its ability to induce opacity and increased permeability in an isolated bovine cornea.
The test was performed according to the Method B.47 Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage, Adopted 14th February 2017
The test was performed using nine isolated bovine corneas. The testing was performed on three groups of corneas: test item treatment group, positive control group and negative control group. Three corneas per group were used.
The test item was tested as suspension prepared from test item at 20% concentration in a 0.9% sodium chloride solution.
The closed-chamber method was used, because the test item was applicable by micropipette. The opacity and permeability of each cornea were measured. The In Vitro Irritancy Score (IVIS) was calculated from the values of opacity and permeability.
The In Vitro Irritancy Score (IVIS) for 5-aminotetrazole was 8.60. The corneas treated by the test item were without macroscopic damage.
This value of IVIS is > 3 and simultaneously ≤ 55 therefore the classification according to UN GHS criteria for eye irritation or serious eye damage is: no prediction can be made.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12.12.2017 - 14.12.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Adopted: 28 July 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Protocol: EpiOcularTM EIT for the prediction of acute ocular irritation of chemicals
- Version / remarks:
- Version 9, June 29, 2015, MatTek corp.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- human
- Strain:
- other: keratinocyte strain 4F1188
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability
Cell damage (cytotoxicity), playing an important, if not the primary, mechanistic role in determining the overall serious eye damage/eye irritation response of a chemical regardless of the physicochemical processes underlying tissue damage, is followed in this test.
This test uses an in vitro procedure allowing the identification of chemicals not requiring classification and labelling for eye irritation or serious eye damage in accordance with UN GHS. This test is not able to distiguih between serious eye damage and eye irritation.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live
The RhCE tissues are reconstructed from primary human cells, which have been cultured for several days to form a stratified, highly differentiated squamous epithelium, morphologically similar to that found in the human cornea. The EpiOcular™ RhCE tissue construct consists of at least 3 viable layers of cells and a non-keratinized surface, showing a cornea-like structure analogous to that found in vivo.
The reconstructed human cornea-like epithelial model EpiOcular™ comes from MatTek, Bratislava, SK, supplied with Certificate of Analysis. Lot No. of tissues used for this test: 27017 kit B.
On the day of receipt, EpiOcularTM tissues were conditioned to release transport stress related compounds and debris by incubation in assay medium delivered by MatTek for test performance for 62 minutes at standard culture conditions and, after media replacement, overnight (following 18 hours 28 minutes) also standard at culture conditions. - Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- The test substance (50 mg of substance/surface ratio 39.7 uL/cm2) is placed directly atop to the tissue moistened with 20 µL of PBS. The test substance was spread over entire tissue surface.
A single testing, composed of two replicate tissues, was run. - Duration of treatment / exposure:
- 6 hours
- Duration of post- treatment incubation (in vitro):
- 25±2 mins immersion incubation (post-soak)
18 hours at standard culture conditions (post-treatment incubation) - Number of animals or in vitro replicates:
- 2
- Details on study design:
- - Details of the test procedure used
Direct MTT reduction - functional check in tubes => The test was performed as a part of another study: Study No. 413/17/4AC: 5-aminotetrazole - In vitro Skin Corrosion (EpiDermTM Model), VUOS-CETA Report No. 17-693, 2017. No direct-reducing properties were observed.
Colour interference
The test was performed as a part of another study: Study No. 413/17/4AC: 5-aminotetrazole - In vitro Skin Corrosion (EpiDermTM Model), VUOS-CETA Report No. 17-693, 2017. No change of colour was observed.
MTT test
A single testing, composed of 2 replicate tissues, is run (plus 3 for the positive control (PC) and 3 for negative control (NC)).
- RhCE tissue construct used, including batch number
The reconstructed human cornea-like epithelial model EpiOcular™ comes from MatTek, Bratislava, SK.
Lot No. of tissues used for this test: 27017 kit B
- Doses of test chemical and control substances used
The test substance (50 mg of substance/surface ratio 39.7 mg/cm2) is placed directly atop to the tissue moistened with 20 µL of PBS.
PC: Methyl Acetate 99%, MatTek, Lot No. 032817ISA
NC: water for injection Ardeapharma, Lot. No. 1608120439 exp.08/2018
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable)
60 mins at standard culture conditions (37±1°C, 5±1 % CO2, humidified incubator). Tissues were wetted with 20 μl of PBS spread across entire tissue surface. After 30 minutes incubation tissues were topically exposed to the test chemical (50 mg per tissue) for 30 minutes
25 ± 2 minutes immersion incubation (post-soak) at room temperature
18 hours at standard culture conditions (37±1°C, 5±1 % CO2, humidified incubator)
- Description of any modifications to the test procedure:
Assay acceptance criterion was not fulfilled for absorbancies of extracts from positive control tissues. As all the tissues had viabilities under 50% of negative control viability we consider that this deviation has not impact on study results.
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer)
OD570 is measured on a plate reader Biotek Epoch. Isopropyl alcohol serves as a blank. No external filter is used.
- Description of the method used to quantify MTT formazan
Optical density (OD570) of isopropyl alcohol extracts was measured on a plate reader. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.
Then the mean relative tissue viability of two individual tissues exposed to the test substance is calculated – this value is, after correction, used for the comparison with limit value.
Tests for colour interference and direct reduction did not demonstrate influence of colour or reductive properties of the test item on study results. Thus, no steps for correction of results were performed.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model
The percentage tissue viability cut-off value distinguishing classified from non-classified test chemicals is 60%. Results should thus be interpreted as follows:
- The test chemical is identified as not requiring classification and labelling according to UN GHS (No Category) if the mean percent tissue viability after exposure and post-exposure incubation is more than (>) 60%. In this case no further testing in other test methods is required.
- The test chemical is identified as potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1) if the mean percent tissue viability after exposure and post exposure incubation is less than or equal (≤) to 60%.
- Positive and negative control means and acceptance ranges based on historical data
1) The negative control OD > 0.8 and < 2.5,
2) The mean relative viability of the positive control is below 50% of control viability
3) The difference of viability between the two relating tissues of a single chemical is < 20% in the same run. This applies also to the killed controls and the colorant controls which are calculated as percent values related to the viability of the relating negative control. - Irritation parameter:
- other: average viablility
- Run / experiment:
- 1
- Value:
- 2.3
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: i.e. viability was ≤ 60 %
- Other effects / acceptance of results:
- The average negative control (neat extract) OD570 was 1.638 what is > 0.8 and < 2.5. This criterion was fulfilled.
The mean relative viability of the positive control was 20.0 % what is below 50% of negative control viability. This criterion was fulfilled.
The difference of viability between the three relating tissues of the negative control was 11.7 %. The difference of viability between the two relating tissues of the test substance was 12.4 % what is < 20%. These criteria were fulfilled. The difference of viability between the three positive control tissues was 21.0 % what is > 18%. This criterion was not fulfilled (for comment see Any other information ...above).
No problems occurred at treatment but part of the test substance remained not wetted after the treatment period. Bottom layer directly adjoin to tissue was wetted. - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Under the above-described experimental design average viability of treated tissues by the test substance 5-aminotetrazole was 2.3 % of negative control average value i.e. viability was ≤ 60 %. The effect of the test substance was positive in EpiOcularTM model (tissues were damaged).
According to the classification criteria, the test substance, 5-aminotetrazole, is identified as substance potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1). Further testing with other test methods will be required. - Executive summary:
The test substance, 5 -aminotetrazole, was assayed for the in vitro eye irritation in human cornea-like model EpiOcularTM. The test was performed according to the OECD Test Guideline No. 492: Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. Details of the procedure are given in Protocol: EpiOcularTMEye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irritation of chemicals (MatTek 06/29/2015).
After pre-incubation and wetting of tissues, 50 mg of the test substance was placed directly atop to the tissue and it was spread on the entire tissue surface. Length of exposition was 6 hours at 37±1°C in humidified CO2 incubator (5±1% CO2). Two tissues were used for the test substance and three for every control.
After removal of the test substance, tissues were post-soaked in medium for approximately 25 minutes and post-incubated for about 18 hours at culture conditions. Three hours incubation with MTT and 2-3 hours extraction period with shaking followed then. Optical density (OD570) of isopropyl alcohol extracts was measured on a plate reader. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.
Tests for colour interference and direct reduction were performed as a part of another study (Study No. 413/17/4AC: 5-aminotetrazole - In vitro Skin Corrosion (EpiDermTM Model), VUOS-CETA Report No. 17-693, 2017). Neither direct reducting properties nor colour interference with endpoint were found.
Under the above-described experimental designaverage viability of treated tissues was 2.3% i.e. viability was ≤60 %.
The effect of the test substancewaspositiveinEpiOcularTMmodel (tissues were damaged).
According to the classification criteria, the test substance, 5-aminotetrazole, is identified as substance potentially requiring classification and labelling according to UN GHS (Category 2 or Category 1). Further testing with other test methods will be required.
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02.04. – 30.04.2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- Version / remarks:
- Commission Regulation (EU) 2017/735,
Published in O.J.L. 112, 2017 - Deviations:
- yes
- Remarks:
- See Any other information (a temperature deviation without impact on study)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- Adopted October 2, 2012
- Deviations:
- yes
- Remarks:
- See Any other information (a temperature deviation without impact on study)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: breeding farm VELAZ s.r.o., Lysolaje, Czech Republic, RČH CZ 21760118
- Weight at study initiation: 2.90 – 3.20 kg
- Housing: conventional animal room – individually in metallic cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days, no signs of disease were observed
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3°C, permanently monitored
- Humidity (%): 30 – 70%, permanently monitored
- Photoperiod (hrs dark / hrs light): 12 h/12 h - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- A dose of 0.1g of the test substance was applied to the test site.
- Duration of treatment / exposure:
- The test substance was placed into the conjunctival sac of one eye of animals after gently pulling the lower lid away from the eyeball. The lids were then gently held together for about one second in order to prevent loss of the substance.
The other eye, which was untreated, serves as a control.
The substance was solid and has not been removed from the eye of the test animal by physiological mechanisms at the first observation time point of 1 hour after treatment. The eye was rinsed with physiological saline solution. - Observation period (in vivo):
- examined at 1, 24, 48 and 72 hours after application
- Number of animals or in vitro replicates:
- 2 animals
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): rinsed with physiological saline solution
- Time after start of exposure: 1h
SCORING SYSTEM:
To the ocular reactions observed at each time interval the grades were assigned according to the grading system given in Method B.5 – Acute Eye Irritation/Corrosion, Commission Regulation (EU) 2017/735, Published in O.J.L. 112, 2017
TOOL USED TO ASSESS SCORE: After recording the observations at 72 hours, the eyes of rabbit were examined with the hand slit-lamp. - Irritation parameter:
- cornea opacity score
- Basis:
- animal: 13
- Time point:
- 24 h
- Score:
- 1
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 13
- Time point:
- 48 h
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 13
- Time point:
- 72 h
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 13
- Time point:
- other: 4th day - 5th day
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 13
- Time point:
- other: 6th day -14thday
- Score:
- 1
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 13
- Time point:
- other: 15th day - 16th day
- Score:
- 0
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 14
- Time point:
- 48 h
- Score:
- 3
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 14
- Time point:
- 24 h
- Score:
- 3
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 14
- Time point:
- other: 4th day - 6th day
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- iris score
- Basis:
- animal: 13
- Time point:
- 24 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: next 24 h
- Irritation parameter:
- conjunctivae score
- Basis:
- animal: 13
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 3
- Irritation parameter:
- chemosis score
- Basis:
- animal: 13
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 14
- Time point:
- 72 h
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- iris score
- Basis:
- animal: 14
- Time point:
- 24 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: next 24 h
- Irritation parameter:
- conjunctivae score
- Basis:
- animal: 14
- Time point:
- 24/48 h
- Score:
- 1
- Max. score:
- 3
- Irritation parameter:
- chemosis score
- Basis:
- animal: 14
- Time point:
- 24/48 h
- Score:
- 1
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal: 14
- Time point:
- other: 7th day - 21th day
- Score:
- 1
- Max. score:
- 4
- Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Conclusions:
- see Executive summary
- Executive summary:
The test item, 5-aminotetrazole, was tested for the assessment of eye irritation/corrosion effects using albino rabbit (New Zealand Albino breed).
The test was performed according the following documents:
- Method B.5 – Acute Eye Irritation/Corrosion, Commission Regulation (EU) 2017/735, Published in O.J.L. 112, 2017
- The OECD Test Guideline No. 405 Acute Eye Irritation/Corrosion. Adopted October 9, 2017
Before in vivo testing, the sequential testing strategy as it is recommended in supplement to TG 405 (2012) was respected. The results did not allow the classification of test item with regard to its potential to cause eye irritation or serious eye damage.
Therefore in vivo test was started. The test was performed initially using one animal (No. 13). Because no corrosive or severe irritating effects were observed in the initial test, the response should be confirmed in additional animals. Only one additional animal (No. 14) was used, because an irritant effect was observed in the initial test.
The following changes were observed on eye during the 72 hours observation period after administration of the test item:
cornea - diffuse areas of opacity or easily discernible translucent area with details of iris slightly obscured, conjuctivae - some blood vessels hyperaemic, chemosis – swelling above normal, iris – markedly deepened rugae, were observed in rabbit No. 13.
Cornea - easily discernible translucent area with details of iris slightly obscured or nacrous area, no details of iris visible, conjuctivae – some blood vessels hyperaemic, chemosis – swelling above normal, iris - markedly deepened rugae, were observed during the 72 hours observation period after administration of the test item in rabbit No.14.
Easily discernible translucent area, details of iris slightly obscured in the cornea were not fully reversible during the first 72 hours in rabbit No. 13 and No. 14. Diffuse areas of opacity were observed till the 14th day after administration of the test item in rabbit No. 13. The lesions of the cornea have not disappeared during the whole observation period in rabbit No.14 (21th days).
No clinical signs of systemic intoxication were detected.
Evaluation of results after single application demonstrated, that the test item, 5-aminotetrazole, is irritating for the eye of the rabbit. The lesions of the cornea were irreversible.
Referenceopen allclose all
The In Vitro Irritancy Score (IVIS) was computed according the following formula:
IVIS = mean opacity value + (15 x mean permeability OD490 value)
Group |
IVIS calculation |
Result |
NC (0.9% NaCl) |
0.73 + 15 x 0.008 |
0.85 |
PC (20% Imidazole in 0.9% NaCl) |
45.69 + 15 x 1.801 |
72.71 |
Test item (5-aminotetrazole) |
8.58 + 15 x 0.001 |
8.60 |
Table 1: OD570values obtained at the MTT test, their averages, standard deviations (%) and relative viabilities
The data presented are corrected by subtraction of OD570 isopropyl alcohol itself (blank, 0.040).
Code |
Treatment |
OD570 |
mean |
SD |
Viability %
|
||
Tissue 1 |
Tissue 2 |
Tissue 3 |
%SD |
||||
NC |
water |
1.488 |
1.516 |
1.909 |
1.638 |
0.175 |
100.0 |
% NC |
90.9 |
92.5 |
116.6 |
100.0 |
11.7 |
||
C3 |
413/17 |
0.034 |
0.043 |
NT |
0.038 |
0.005 |
2.3 |
% NC |
2.0 |
2.6 |
NT |
2.3 |
12.4 |
||
PC |
99% MA |
0.321 |
0.247 |
0.414 |
0.327 |
0.069 |
20.0 |
% NC |
19.6 |
15.1 |
25.3 |
20.0 |
21.0 |
No alterations of control eyes were observed during the whole study.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on in vitro/ex vivo and in vivo tests the test substance 5-aminotetrazole was non-irritating for skin and irritating for eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.